echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Active Ingredient News > Study of Nervous System > Mol Psychiatry—Jiang Bo's research group at Nantong University reveals a new molecular mechanism by which chronic stress induces depressive-like symptoms through HPA axonal excitation

    Mol Psychiatry—Jiang Bo's research group at Nantong University reveals a new molecular mechanism by which chronic stress induces depressive-like symptoms through HPA axonal excitation

    • Last Update: 2023-01-01
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com


    Written by Jiang Bo

    Responsible editor—Wang Sizhen, Fang Yiyi

    Editor—Sizhen Wang


    As we all know, depression is caused by the interaction of physiological, psychological, genetic and other factors, of which chronic stress is an important trigger
    .
    Multi-year studies have shown that
    hyperfunction of the hypothalamic-pituitary-adrenal (HPA) axis is involved in the neurobiological process of depression [1-3
    ].

    Chronic stress causes the
    HPA axis to release excess glucocorticoids, which continuously and intensively agitate glucocorticoid receptors in neurons in brain regions such as the hippocampus, causing neuronal atrophy, dendritic spine loss, nerve damage, and decreased synthesis of brain-derived neurotrophic factor (BDNF) [4-8
    ].

    However, the molecular mechanism by which chronic stress causes hypothalamic paraventricular nuclear neurons to synthesize and release excess adrenocorticotropin-releasing hormone (CRH) and cause HPA axis hyperactivity remains unclear
    .


    The biosynthesis of CRH is known to be regulated by cyclic adenosine monophosphate reactive element binding protein (CREB)[9], and CREB function is regulated by CREB transcriptionally regulated coactivators ( CRTC1/2/3) is regulated [10-12], while CRTC1/2/3 activity is controlled by salt-induced kinase (SIK1/2/3) (SIK Regulates the transport of CRTC into the nucleus, affecting the formation of CRTC-CREB complexes) [13-17].

    Several studies have reported that the transcriptional synthesis of CRH and HPA axis hyperactivity require the joint action of CRTC and CREB in the hypothalamic nucleus, and they are positively correlated
    [18-20]
    。 This can raise a question:
    whether chronic stress can affect the expression of SIK in the hypothalamus, thereby regulating the formation of intranuclear CRTC-CREB complexes, thereby greatly promoting the active function of CREB and excessive synthesis and secretion CRH, which causes HPA axis hyperactivity and eventually induces depression?


    On November 25, 2022, Jiang Bo's research group from the School of Pharmacy of Nantong University published a paper in Molecular Psychiatry ) was published entitled "Salt-inducible kinase 1-CREB-regulated transcription coactivator 1 signalling in the paraventricular nucleus of the.
    " hypothalamus plays a role in depression by regulating the hypothalamic-pituitary-adrenal axis
    "
    , which found the hypothalamic paraventricular nucleus SIK1 It promotes HPA axis hyperactivity by positively regulating the CRTC1-CREB-CRH pathway, and thus mediates the process of chronic stress-induced depression.
    Overexpression increases paraventricular nuclear
    SIK1 function and produces significant antidepressant effects;
    Paraventricular nuclear SIK1 is involved in the pharmacological effects
    of clinical antidepressants fluoxetine, paroxetine, venlafaxine and duloxetine.
    In addition, the paper has been invited as a journal cover article
    .



    The researchers first found (Figure 1) that two classical models of depression, chronic social frustration stress (CSDS) and chronic unpredictable mild stress (CUMS), were induced The depressive-like behavior of C57BL/6I mice significantly reduced the protein and mRNA expression levels of SIK1 in the paraventricular nucleus of the hypothalamus (by more than 60%), without affecting the paraventricular nucleus Protein and mRNA expression levels
    of SIK1 and SIK3.
    Subsequently
    , both CSDS and CUMS were found to significantly increase the level of intranuclear CRTC1 protein in paraventricular nuclear neurons, while significantly reducing their cytoplasmic pCRTC1 ( Ser-151) levels without affecting the nucleus CRTC2, CRTC3, and cytoplasmic pCRTC2 (Ser-171 ) with the level of
    pCRTC3 (Ser-163).
    qRT-PCR and Co-IP experiments have found that both CSDS and CUMS have a significant increase in CRTC1-mRNA in the paraventricular nucleus levels (about 50% increase) and intranuclear CRTC1-CREB binding levels
    .
    This preliminarily indicates that the SIK1-CRTC1 pathway in the PVN region is involved in the process
    of chronic stress-induced depression.


    Figure 1 Chronic stress significantly alters the level of the SIK1-CRTC1 signaling pathway in the paraventricular nucleus of mice in the hypothalamic nucleus.

    (Source: Wang Y, et al.
    , Mol Psychiatry, 2022)

    Step 2 (Figure 2), The researchers achieved silence (about 70% reduction) of paraventricular nuclear SIK1 levels in normal C57BL/6I mice through AAV-SIK1-shRNA-EGFP, and subsequent behavioral tests found that they showed obvious depressive manifestations such as anhedonia, hopelessness, and social fear, without affecting autonomous mobility.
    Subsequent molecular biology tests showed that these behaviors were accompanied by significant increases in paraventricular
    CRH expression, intranuclear CRTC1 levels, cytoplasmic pCRTC1 levels, and intranuclear CRTC1-CREB binding levels
    .
    Western blotting, immunofluorescence and ELISA successively confirmed that SIK1-shRNA silencing parachamber nucleus SIK1 not only significantly reduced the level of BDNF signaling pathway in the hippocampus and intermediate prefrontal cortex.
    Decreased hippocampal neurogenesis levels also significantly increased plasma cortisol and adrenocorticotropic hormone
    (ACTH) release levels (indicating HPA axis hyperactivity).

    This directly proves that the downregulation of paraventricular nuclear SIK1 is an important trigger
    for depression.

    Figure 2.
    AAV
    virus gene silencing of paraventricular nuclear SIK1 expression in normal mice can induce many depressive symptoms
    .
    (Source: Wang Y, et al.
    , Mol Psychiatry, 2022)

    (Figures 3&4), the researchers used AAV-SIK1-EGFP (overexpression effect greater than 150%) to block the paraventricular nucleus SIK1 induced by CSDS and CUMS models Level drop.

    Relevant behavioral tests showed that
    AAV-SIK1-EGFP significantly reversed depressive behaviors such as anhedonia, hopelessness, helplessness, and social phobia caused by CSDS and CUMS stress.
    Related molecular biology experiments confirmed that
    AAV-SIK1-EGFP significantly reversed the increase in paraventricular nuclear CRH expression, the increase of intranuclear CRTC1 level, the decrease of cytoplasmic pCRTC1 level, and the intranuclear caused by CSDS and CUMS CRTC1-CREB binding levels increased, BDNF signaling pathways in the hippocampus and intermediate prefrontal cortex were reduced, and hippocampal neurogenesis levels decreased
    .
    Further use of TAT-SIK1 recombinant protein overexpressing paraventricular nuclear SIK1 was found to be similar to AAV-SIK1-EGFP, TAT-SIK1 also completely reversed CSDS and CUMS This results in depressive-like behavior and many pathologic symptoms
    .
    This directly confirms that the paraventricular nuclear
    SIK1 interference target can exert antidepressant effects
    .

    Figure 3.
    AAV virus gene overexpression of paraventricular nuclear SIK1 levels in depressive model mice reverses chronic stress-induced depression-like behavior
    .
    (Source: Wang Y, et al.
    , Mol Psychiatry, 2022)

    Figure 4.
    AAV
    virus gene overexpression of paraventricular nuclear SIK1 levels in depressive model mice reverses depressive stress-induced depressive pathological molecular changes
    .
    (Source: Wang Y, et al.
    , Mol Psychiatry, 2022)

    5) It was found that fluoxetine, paroxetine, venlafaxine and duloxetine, which are classic SSRI and SNRI antidepressants, significantly reverse the paraventricular nuclear SIK1 protein caused by CSDS and CUMS mRNA levels decreased, CRTC1-mRNA levels increased, intranuclear CRTC1 levels increased, cytoplasmic pCRTC1 levels decreased, and intranuclear CRTC1-CREB binding levels increased.

    Conversely, the expression of
    SIK1 in the parachamber nucleus using SIK1-shRNA silence caused drugs such as fluoxetine to no longer be able to reverse CSDS and CUMS, resulting in antidepressant effects.

    This further suggests that paraventricular nuclear SIK1 can be used as an antidepressant target
    .

    Figure 5 Both clinical antidepressants fluoxetine and venlafaxine reverse the effects of
    chronic stress on the paraventricular nuclear SIK1-CRTC1-CRH pathway.
    (Source: Wang Y, et al.
    , Mol Psychiatry, 2022)

    Figure 6 Work summary diagram (Source: Wang Y, et al.
    , Mol Psychiatry, 2022)

    In summary, researchers comprehensively apply animal models, behavioral methods, Molecular biology techniques and various methods such as gene intervention/overexpression, comprehensive scientific studies have explored the role of the hypothalamic paraventricular nuclear SIK-CRTC system in the neurobiology of depression and concluded that chronic stress increases its intranuclear by reducing paraventricular nuclear SIK1 expression CRTC1-CREB complex formation, which in turn greatly promotes the active function of CREB, synthesizes and secretes excessive CRH, causes HPA axis hyperactivity and ultimately induces depression ( Figure 6).

    It not only expands the research understanding of the pathological mechanism of depression, but also clarifies the intrinsic molecular mechanism of HPA axis hyperactivity caused by chronic stress for the first time, and is a deepening and supplement to the "depression HPA axis hypothesis".
    It also directly confirms that paraventricular nuclear
    SIK1 is an effective and reliable new antidepressant target, and the development of selective SIK1 agonists can become a new strategy for the development of antidepressant drugs in the future, which has significant clinical value and significance
    .

    Original link: https://pubmed.
    ncbi.
    nlm.
    nih.
    gov/36434056/

    corresponding author Jiang Bo (Photo courtesy of: Jiang Bo Laboratory, School of Pharmacy, Nantong University) Corresponding author profile (swipe up and down to read).

    Jiang Bo, male, currently working in the School of Pharmacy, Nantong University, professor, doctoral supervisor, member of Chinese Pharmacological Society, member of Jiangsu Pharmacological Society, Ph.
    D.
    in Department of Pharmacology, School of Basic Medical Sciences, Huazhong University of Science and Technology, postdoctoral

    fellow at University of Iowa.
    He has long been committed to the research of the pathophysiological mechanism of depression, and has a strong interest
    in finding new antidepressant targets and screening new antidepressant drugs.
    He has published
    more than 40 SCI research papers, including more than 30 first authors/corresponding authors; Won 3 municipal academic awards; He is presided over or has completed 7 national, provincial and ministerial natural science foundations
    .
    The research work in this news was supported by the National Natural Science Foundation of China (
    81873795
    ).


    Welcome to scan the code to join Logical Neuroscience Literature learning 2 group remarks format: Name--Research field-Degree/Title/Title/ Position Selected articles from previous issues [1] Nat Commun-Chen Zhong/Wang Yi's team revealed a new mechanism of astrocytes involved in seizures [2] Cell Mol Life Sci-Li Huawei / He Yingzi team found that KDM5A is expected to become a new target for the prevention and treatment of sensorineural deafness [3] Review Article Recommendation Topic No.
    1—Selected Reviews of the Latest Frontiers in the Field of Neuroscience in Cell Journal (October 11-11, 2022)
    [4] Nat Immunol—Zhirong Zhang et al.
    reveal a new mechanism of innate immune activation: NLRP3 inflammasome sensing changes in endosomal stress [
    5].
    CMLS-Zhou Zhidong's team unveiled the pathological mechanism of tyrosine hydroxylase-dopamine pathway in Parkinson's disease [6] Biol Psychiatry| A new mechanism of autistic and schizophrenic-like behavior in mice: CYFIP1 regulates the translation of NMDA receptor complexes [7] Aging
    Cell—Zhang's team reveals the role of homocysteine-modified α-synuclein in Parkinson's disease [8] Hum Brain Mapp—Huang Yan's research group from Shenzhen Advanced Hospital reveals a new function of the visual pathway of large cells under the human cortex [9] Mol Psychiatry Review—the effect of social isolation on brain development, brain function and behavior and its mechanism [10] iScience—Xu Shuhua's team analyzes the adaptive evolution of vitamin B1 metabolic genes in East Asian populationsNeuroAI Reading Club[1】NeuroAI Reading Club Launched—Exploring the Frontier Intersection
    of Neuroscience and Artificial Intelligence Recommended High-quality Scientific Research Training Courses [1] Symposium on Patch-Clamp and Optogenetics and Calcium Imaging Technology (January 7-8, 2023 Tencent Meeting)【2】The 10th NIR Training Camp (Online: 2022.
    11.
    30~12.
    20)【3】The 9th EEG Data Analysis Flight (Training Camp: 2022.
    11.
    23-12.
    24)
    Welcome to "Logical Neuroscience" 【1】" Logical Neuroscience "Recruitment of Editor/Operation Position (Online Office)【2】" Logical Neuroscience "Recruitment of Deputy Editor/Editor/Operation Position (Online Office)[3] Recruitment - " Logical Neuroscience " Recruitment ( Online Part-time, Online Office)
    References (swipe up and down to read).

    1.
    Juruena MF, Bocharova M, Agustini B, Young AH.
    Atypical depression and non-atypical depression: Is HPA axis function a biomarker? A systematic review.
    J Affect

    Disord.
    2017, [Epub ahead of print].

    2.
    Fischer S, Macare C, Cleare AJ.
    Hypothalamic-pituitary-adrenal (HPA) axis functioning as predictor of antidepressant response-Meta-analysis.
    Neurosci Biobehav Rev.
     2017, 83:

    200-211.

    3.
    Maric NP, Adzic M.
    Pharmacological modulation of HPA axis in depression - new avenues for potential therapeutic benefits.
    Psychiatr Danub.
     2013, 25(3): 299-305.

    4.
    Spiers JG, Chen HJ, Sernia C, Lavidis NA.
    Activation of the
     hypothalamic-pituitary-adrenal stress axis induces cellular oxidative stress.
    Front

    Neurosci.
     2015, 8: 456.
     

    5.
    Chen H, Lombès M, Le Menuet D.
    Glucocorticoid receptor represses brain-derived neurotrophic factor expression in neuron-like cells.
    Mol Brain.
     2017, 10(1): 12.

    6.
    Tanokashira D, Morita T, Hayashi K, Mayanagi T, Fukumoto K, Kubota Y, Yamashita

    7.
    T, Sobue K.
    Glucocorticoid suppresses dendritic spine development mediated by down-regulation of caldesmon expression.
    J Neurosci.
     2012, 32(42): 14583-14591.

    8.
    Schoenfeld TJ, Gould E.
    Differential effects of stress and glucocorticoids on adult neurogenesis.
    Curr Top Behav Neurosci.
     2013, 15: 139-164.

    9.
    Wang N, Ma H, Li Z, Gao Y, Cao X, Jiang Y, Zhou Y, Liu S.
    Chronic unpredictable stress exacerbates surgery-induced sickness behavior and neuroinflammatory responses via glucocorticoids secretion in adult rats.
    PLoS One.
     2017, 12(8): e0183077.

    10.
    Andrisani OM.
    CREB-mediated transcriptional control.
    Crit Rev Eukaryot Gene Expr.
     1999, 9(1): 19-32.

    11.
    Saura CA, Cardinaux JR.
    Emerging Roles of CREB-Regulated Transcription Coactivators in Brain Physiology and Pathology.
    Trends Neurosci.
     2017, 40(12): 720-733.

    12.
    Bittinger MA, McWhinnie E, Meltzer J, Iourgenko V, Latario B, Liu X, Chen CH, Song C, Garza D, Labow M.
    Activation of cAMP response element-mediated gene expression by regulated nuclear transport of TORC proteins.
    Curr Biol.
     2004, 14(23): 2156-2161.

    13.
    Conkright MD, Canettieri G, Screaton R, Guzman E, Miraglia L, Hogenesch JB, Montminy M.
    TORCs: transducers of regulated CREB activity.
    Mol Cell.
     2003, 12(2): 413-423.

    14.
    Takemori H, Kajimura J, Okamoto M.
    TORC-SIK cascade regulates CREB activity through the basic leucine zipper domain.
    FEBS J.
     2007, 274(13): 3202-3209.
     

    15.
    Phu do T, Wallbach M, Depatie C, Fu A, Screaton RA, Oetjen E.
    Regulation of the CREB coactivator TORC by the dual leucine zipper kinase at different levels.
    Cell Signal.
     2011; 23(2): 344-353.

    16.
    Horike N, Takemori H, Katoh Y, Doi J, Okamoto M.
    Roles of several domains identified in the primary structure of salt-inducible kinase (SIK).
    Endocr Res.
     2002, 28(4): 291-294.

    17.
    Katoh Y, Takemori H, Lin XZ, Tamura M, Muraoka M, Satoh T, Tsuchiya Y, Min L, Doi J, Miyauchi A, Witters LA, Nakamura H, Okamoto M.
    Silencing the constitutive active transcription factor CREB by the LKB1-SIK signaling cascade.
    FEBS J.
    2006, 273(12): 2730-2748.

    18.
    Takemori H, Okamoto M.
    Regulation of CREB-mediated gene expression by salt inducible kinase.
    J Steroid Biochem Mol Biol.
     2008, 108(3-5): 287-291.

    19.
    Liu Y, Coello AG, Grinevich V, Aguilera G.
    Involvement of transducer of regulated cAMP response element-binding protein activity on corticotropin releasing hormone transcription.
    Endocrinology.
     2010, 151(3): 1109-1118.

    20.
    Martín F, Núñez C, Marín MT, Laorden ML, Kovács KJ, Milanés MV.
    Involvement of noradrenergic transmission in the PVN on CREB activation, TORC1 levels, and pituitary-adrenal axis activity during morphine withdrawal.
    PLoS One.
     2012, 7(2): e31119.

    21.
    Aguilera G, Liu Y.
    The molecular physiology of CRH neurons.
    Front Neuroendocrinol.
    2012, 33(1): 67-84.



    End of article

    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.